IceCure Medical Ltd. Ordinary Shares (ICCM) Stock Price

ICCMStock

$2.28−91.43%52W

Market Cap$7.81M

P/E—

PEG Ratio—

Div yield—

Beta0.41

ICCM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-98.21%

Price vs S&P 500 (4W)-21.69%

VGM Score44.46

Book Value / Share (Quarterly)$3.14

P/TBV (Annual)1.33x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)3.03%

Cash Flow / Share (Quarterly)$-5.50

Price vs S&P 500 (YTD)-99.55%

Gross Margin (TTM)36.55%

Net Profit Margin (TTM)-441.60%

EPS (TTM)$-5.33

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-5.33

Revenue Growth (5Y)-2.68%

EPS (Annual)$-7.11

ROI (Annual)-166.36%

Gross Margin (Annual)36.28%

Net Profit Margin (5Y Avg)-430.69%

Cash / Share (Quarterly)$3.00

Revenue Growth QoQ (YoY)25.66%

ROA (Last FY)-108.42%

Revenue Growth TTM (YoY)8.92%

EBITD / Share (TTM)$-0.94

ROE (5Y Avg)-122.46%

Operating Margin (TTM)-439.94%

Cash Flow / Share (Annual)$-5.99

P/B Ratio0.97x

P/B Ratio (Quarterly)2.88x

Net Income / Employee (Annual)$-224,700

EV / Revenue (TTM)0.04x

Net Interest Coverage (TTM)-69.75x

ROA (TTM)-119.13%

EPS Incl Extra (Annual)$-7.11

Current Ratio (Annual)2.61x

Quick Ratio (Quarterly)1.75x

3-Month Avg Trading Volume2.33M

52-Week Price Return-91.43%

Revenue / Employee (TTM)$53,200

Tangible BV / Share (Quarterly)$0.48

P/S Ratio (Annual)2.44x

Asset Turnover (Annual)0.24x

52-Week High$42.00

Operating Margin (5Y Avg)-436.51%

EPS Excl Extra (Annual)$-7.11

CapEx CAGR (5Y)-30.37%

26-Week Price Return-86.96%

Quick Ratio (Annual)1.96x

13-Week Price Return-67.89%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.52x

Enterprise Value$136,700

Revenue / Share Growth (5Y)47.82%

Asset Turnover (TTM)0.27x

Revenue / Employee (Annual)$50,400

Inventory Turnover (Annual)0.93x

Pretax Margin (Annual)-445.61%

Cash / Share (Annual)$3.65

3-Month Return Std Dev435.67%

Gross Margin (5Y Avg)44.14%

Net Income / Employee (TTM)$-235,000

ROE (Last FY)-166.36%

Net Interest Coverage (Annual)-153.74x

EPS Basic Excl Extra (Annual)$-7.11

Receivables Turnover (TTM)12.42x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-5.33

Receivables Turnover (Annual)12.24x

ROI (TTM)-198.32%

P/S Ratio (TTM)2.31x

Pretax Margin (5Y Avg)-430.69%

Revenue / Share (Annual)$1.59

Tangible BV / Share (Annual)$0.56

Price vs S&P 500 (52W)-109.74%

Year-to-Date Return-87.60%

5-Day Price Return-12.69%

EPS Normalized (Annual)$-7.11

ROA (5Y Avg)-81.28%

Net Profit Margin (Annual)-445.61%

Month-to-Date Return-21.45%

Cash Flow / Share (TTM)$-0.41

EBITD / Share (Annual)$-6.98

Operating Margin (Annual)-446.70%

ROI (5Y Avg)-122.46%

EPS Basic Excl Extra (TTM)$-5.33

P/TBV (Quarterly)1.53x

P/B Ratio (Annual)4.63x

Inventory Turnover (TTM)0.97x

Pretax Margin (TTM)-441.60%

Book Value / Share (Annual)$3.71

Price vs S&P 500 (13W)-70.69%

Beta0.41x

Revenue / Share (TTM)$1.45

ROE (TTM)-211.73%

52-Week Low$2.12

vGradeA

gGradeC

mGradeF

vgmGradeC

ICCM Earnings Surprise History

Q2 25-1.80est. -1.95

Q3 25-1.80est. -1.65

Q4 25-1.80est. -1.20

Q1 26-1.80est. -1.20

Q2 26-1.37est. -1.38

ICCM Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.11

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
ICCMIceCure Medical Ltd. Ordinary Shares	A	C	F	$2.28
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About IceCure Medical Ltd. Ordinary Shares

Icecure Medical develops minimally invasive cryoablation systems using liquid nitrogen to treat solid tumors across multiple indications, including breast, lung, kidney, and bone cancers. The company's technology offers patients an alternative to traditional surgical intervention with reduced recovery time and lower risk. As a commercial-stage company, Icecure is focused on expanding adoption of its cryoablation platform across oncology markets.